Executive Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Executive Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$118K	Buy	+3,035	New	+$128K	0.01%	253

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Executive Wealth Management's GNOM Position: Q4 2024 in Review

Executive Wealth Management opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q4 2024: 3,035 shares worth $118K. The stake represents 0.01% of the portfolio and ranks #253 among its holdings.

68 funds tracked by Wall St. Rank hold GNOM as of Q4 2024.

Executive Wealth Management held 3,035 shares of Global X Genomics & Biotechnology ETF worth $118K as of Q4 2024.
Global X Genomics & Biotechnology ETF was a new Executive Wealth Management position in Q4 2024.
Global X Genomics & Biotechnology ETF made up 0.01% of Executive Wealth Management's portfolio in Q4 2024, its #253 holding.
68 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2024.

Based on Executive Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.